Zenas BioPharma (ZBIO) Current Leases (2023 - 2026)
Zenas BioPharma (ZBIO) posted quarterly Current Leases of $1.0 million for Q1 2026, up 14.21% year-over-year from $908000.0 in Q1 2025, and down 7.0% quarter-over-quarter from $1.1 million in Q4 2025.
Zenas BioPharma (ZBIO) Current Leases (2023 - 2026) Analysis & Trends
Zenas BioPharma's Current Leases history runs 4 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Current Leases rose 14.21% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (up 14.21% YoY), while the FY2025 annual figure was $1.1 million, up 42.04% from the prior year.
- Current Leases for Q1 2026 stood at $1.0 million, down from $1.1 million in the prior quarter.
- The five-year high for Current Leases was $1.1 million in Q4 2025, with the low at $384000.0 in Q3 2024.
- The 4-year median for Current Leases is $789000.0 (2024), against an average of $774500.0.
- The sharpest annual moves came in 2025 and 2026: Current Leases jumped 60.94% in 2025, then increased 14.21% in 2026.
- Zenas BioPharma's Current Leases stood at $556000.0 in 2023, then surged by 41.19% to $785000.0 in 2024, then soared by 42.04% to $1.1 million in 2025, then declined by 7.0% to $1.0 million in 2026.
- Business Quant data shows ZBIO's Current Leases at $1.0 million in Q1 2026, $1.1 million in Q4 2025, and $618000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Zenas BioPharma | 1.87 Bn | 748.44 Mn | - | 823,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 823,000.00 |
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 618,000.00 |
| Jun 30, 2025 | 793,000.00 |
| Mar 31, 2025 | 908,000.00 |
| Dec 31, 2024 | 785,000.00 |
| Sep 30, 2024 | 384,000.00 |
| Dec 31, 2023 | 556,000.00 |